Kymera Therapeutics, Inc. (KYMR)
89.66
+1.85
(+2.11%)
USD |
NASDAQ |
Dec 12, 16:00
89.66
0.00 (0.00%)
After-Hours: 20:00
Kymera Therapeutics Profit Margin (Quarterly): -2.97K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 39.21% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Sanofi | -- |
| Cytokinetics, Inc. | -15.81K% |
| TG Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -33.29% |
| Return on Assets | -28.57% |
| Return on Invested Capital | -30.33% |
| Gross Profit Margin (Quarterly) | 22.25% |
| Operating Margin (Quarterly) | -3.21K% |
| Return on Net Operating Assets | -274.3% |